-
What we learned about the feasibility of gene electrotransfer for vaccination on a model of COVID-19 vaccine [Elektronski vir]Kamenšek, Urška ...: DNA vaccination is one of the emerging approaches for a wide range of applications, including prophylactic vaccination against infectious diseases and therapeutic vaccination against cancer. The ... aim of this study was to evaluate the feasibility of our previously optimized protocols for gene electrotransfer (GET)-mediated delivery of plasmid DNA into skin and muscle tissues on a model of COVID-19 vaccine. Plasmids encoding the SARS-CoV-2 proteins spike (S) and nucleocapsid (N) were used as the antigen source, and a plasmid encoding interleukin 12 (IL-12) was used as an adjuvant. Vaccination was performed in the skin or muscle tissue of C57BL/6J mice on days 0 and 14 (boost). Two weeks after the boost, blood, spleen, and transfected tissues were collected to determine the expression of S, N, IL-12, serum interferon-γ, the induction of antigen-specific IgG antibodies, and cytotoxic T-cells. In accordance with prior in vitro experiments that indicated problems with proper expression of the S protein, vaccination with S did not induce S-specific antibodies, whereas significant induction of N-specific antibodies was detected after vaccination with N. Intramuscular vaccination outperformed skin vaccination and resulted in significant induction of humoral and cell-mediated immunity. Moreover, both boost and adjuvant were found to be redundant for the induction of an immune response. Overall, the study confirmed the feasibility of the GET for DNA vaccination and provided valuable insights into this approach.Vir: Pharmaceutics [Elektronski vir]. - ISSN 1999-4923 (Vol. 15, no. 7, 2023, str. [1-18])Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2023Jezik - angleškiCOBISS.SI-ID - 159538947
Avtor
Kamenšek, Urška |
Čemažar, Maja |
Kranjc Brezar, Simona |
Jesenko, Tanja |
Kos, Špela, farmacija |
Žnidar, Katarina |
Markelc, Boštjan |
Pišljar, Živa |
Komel, Tilen |
Gorše, Tim |
Reberšek, Eva |
Jakopič, Helena |
Serša, Gregor
Teme
DNK cepiva |
elektroprenos genov |
cepiva proti covidu-19 |
DNA vaccination |
gene electrotransfer |
COVID-19 vaccine
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Kamenšek, Urška | 28387 |
Čemažar, Maja | 14575 |
Kranjc Brezar, Simona | 19058 |
Jesenko, Tanja | 33227 |
Kos, Špela, farmacija | 36366 |
Žnidar, Katarina | 37534 |
Markelc, Boštjan | 32175 |
Pišljar, Živa | 54718 |
Komel, Tilen | 53504 |
Gorše, Tim | ![]() |
Reberšek, Eva | ![]() |
Jakopič, Helena | ![]() |
Serša, Gregor | 08800 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.